142 related articles for article (PubMed ID: 10906733)
1. Calcitonin and calcitonin gene-related peptide in the human prostate gland.
Abrahamsson PA; Dizeyi N; Alm P; di Sant'Agnese PA; Deftos LJ; Aumüller G
Prostate; 2000 Aug; 44(3):181-6. PubMed ID: 10906733
[TBL] [Abstract][Full Text] [Related]
2. Relationship of neuroendocrine cells of prostate and serotonin to benign prostatic hyperplasia.
Cockett AT; di Sant'Agnese PA; Gopinath P; Schoen SR; Abrahamsson PA
Urology; 1993 Nov; 42(5):512-9. PubMed ID: 7694415
[TBL] [Abstract][Full Text] [Related]
3. Small cell lung carcinoma cell lines express mRNA for calcitonin and alpha- and beta-calcitonin gene related peptides.
Kelley MJ; Snider RH; Becker KL; Johnson BE
Cancer Lett; 1994 Jun; 81(1):19-25. PubMed ID: 8019984
[TBL] [Abstract][Full Text] [Related]
4. Presence of calcitonin-like immunoreactivity (iCT) in human prostate gland: evidence for iCT secretion by cultured prostate cells.
Shah GV; Noble MJ; Austenfeld M; Weigel J; Deftos LJ; Mebust WK
Prostate; 1992; 21(2):87-97. PubMed ID: 1409122
[TBL] [Abstract][Full Text] [Related]
5. In-situ analysis of calcitonin and CGRP expression in medullary thyroid carcinoma.
Boultwood J; Wynford-Thomas D; Richards GP; Craig RK; Williams ED
Clin Endocrinol (Oxf); 1990 Sep; 33(3):381-90. PubMed ID: 2253409
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis.
Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF
Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of calcitonin gene-related peptide in human medullary carcinoma and C cell hyperplasia.
Williams ED; Ponder BJ; Craig RK
Clin Endocrinol (Oxf); 1987 Jul; 27(1):107-14. PubMed ID: 3498562
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of calcitonin gene-related peptide (CGRP) in a rat medullary thyroid carcinoma cell line.
Schifter S; Johansen TE; Johnsen AH
Peptides; 1995; 16(8):1489-96. PubMed ID: 8745063
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.
Steiner GE; Newman ME; Paikl D; Stix U; Memaran-Dagda N; Lee C; Marberger MJ
Prostate; 2003 Aug; 56(3):171-82. PubMed ID: 12772186
[TBL] [Abstract][Full Text] [Related]
10. Amylin/islet amyloid polypeptide expression in medullary carcinoma of the thyroid: correlation with the expression of the related calcitonin/CGRP genes.
Alevizaki M; Dai K; Grigorakis SI; Legon S; Souvatzoglou A
Clin Endocrinol (Oxf); 1994 Jul; 41(1):21-6. PubMed ID: 8050128
[TBL] [Abstract][Full Text] [Related]
11. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.
Aprikian AG; Cordon-Cardo C; Fair WR; Reuter VE
Cancer; 1993 Jun; 71(12):3952-65. PubMed ID: 7685237
[TBL] [Abstract][Full Text] [Related]
12. p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancer.
Schlechte H; Lenk SV; Löning T; Schnorr D; Rudolph BD; Ditscherlein G; Loening SA
Eur Urol; 1998; 34(5):433-40. PubMed ID: 9803007
[TBL] [Abstract][Full Text] [Related]
13. Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue.
Lin VK; Wang D; Lee IL; Vasquez D; Fagelson JE; McConnell JD
Prostate; 2000 Aug; 44(3):193-203. PubMed ID: 10906735
[TBL] [Abstract][Full Text] [Related]
14. A lectin histochemistry comparative study in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
Arenas MI; Romo E; de Gaspar I; de Bethencourt FR; Sánchez-Chapado M; Fraile B; Paniagua R
Glycoconj J; 1999 Jul; 16(7):375-82. PubMed ID: 10619710
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cytokeratin markers to differentiate between benign and malignant prostatic tissue.
Guinan P; Shaw M; Targonski P; Ray V; Rubenstein M
J Surg Oncol; 1989 Nov; 42(3):175-80. PubMed ID: 2478835
[TBL] [Abstract][Full Text] [Related]
16. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.
Cordon-Cardo C; Koff A; Drobnjak M; Capodieci P; Osman I; Millard SS; Gaudin PB; Fazzari M; Zhang ZF; Massague J; Scher HI
J Natl Cancer Inst; 1998 Sep; 90(17):1284-91. PubMed ID: 9731735
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical comparison of chromogranins A and B and secretogranin II with calcitonin and calcitonin gene-related peptide expression in normal, hyperplastic and neoplastic C-cells of the human thyroid.
Schmid KW; Kirchmair R; Ladurner D; Fischer-Colbrie R; Böcker W
Histopathology; 1992 Sep; 21(3):225-32. PubMed ID: 1356907
[TBL] [Abstract][Full Text] [Related]
18. Localization of annexins I, II, IV and VII in whole prostate sections from radical prostatectomy patients.
Lehnigk U; Zimmermann U; Woenckhaus C; Giebel J
Histol Histopathol; 2005 Jul; 20(3):673-80. PubMed ID: 15944914
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
[TBL] [Abstract][Full Text] [Related]
20. Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues.
Ibrahim GK; Kerns BJ; MacDonald JA; Ibrahim SN; Kinney RB; Humphrey PA; Robertson CN
J Urol; 1993 Jan; 149(1):170-3. PubMed ID: 7678041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
